healthcare spending due to chronic diseases
new drug candidates failed in the last decade
phase III clinical trial failures from low efficacy
Understanding disease biology better
The one-size-fits-all ‘blockbuster’ approach to medicine is inefficient for everyone. Biopharma needs better targets that will be more successful in clinical trials, and healthcare needs access to better tools and treatments to provide patients with an accurate diagnosis and precision medicines that work for them.
We identify, target, and help treat the biological mechanisms that are driving disease within subgroups of patients, generating stratification biomarkers to improve and derisk pharmaceutical innovation and enable personalized healthcare.
Driving precision medicine
We've created an AI-led Innovation Engine, powered by our unique combinatorial analytics, to stratify patient populations at the highest resolution, finding all the factors associated with disease for subgroups of patients.
Partner with us to:
✔ Discover novel drug targets and leads for unmet medical needs
✔ Identify drug repositioning candidates for patient subgroups
✔ Accelerate and derisk clinical development
✔ Predict and prevent chronic disease in patients early
✔ Design more accurate diagnostic and clinical decision support tools